Barriers to follow-up care of survivors in the United States and the United Kingdom


  • Kevin C. Oeffinger MD,

    Corresponding author
    1. Department of Pediatrics and Internal Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
    • Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021.
    Search for more papers by this author
  • W. Hamish B. Wallace MD, FRCPCH

    1. Department of Child Life and Health Sciences, University of Edinburgh and the Department of Hematology/Oncology, Royal Hospital for Sick Children, Edinburgh
    Search for more papers by this author


Survivors of pediatric cancer face an increased risk of morbidity, mortality, and diminished quality of life associated with their previous cancer therapy. Because these risks are often modifiable, periodic lifetime medical follow-up is recommended for all survivors. This article assesses the current status of follow-up care in the United States and the United Kingdom. Potential barriers in both cultures and health care environments are described. A better understanding of these barriers has led to the development and testing of interventions intended to optimize the health care of survivors. Pediatr Blood Cancer 2006;46:135–142. © 2005 Wiley-Liss, Inc.